Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Featured
Off
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
POST-CABGDM Trial evaluated the efficacy and safety of empagliflozin in patients with type 2 diabetes mellitus (T2DM) undergoing elective on-pump coronary artery bypass grafting (CABG).
User Segments
Release Date
Featured Order
0
Is Paid
0